NCT02090205

Brief Summary

Background There is no unanimous opinion about a lung-protective strategy in cardiac surgery. Small randomized clinical and animals trials suggest that ventilation during cardio-pulmonary bypass (CPB) could be protective on the lungs. This evidence is based on surrogate end-points and most of studies are limited to elective coronary surgery. According to the available data, an optimal strategy of lung protection during CPB cannot be recommended. The purpose of the CPBVENT study is to investigate the effectiveness of different ventilation strategies during CPB on post-operative pulmonary complications. Trial design The CPBVENT study will be a single-blind, multicenter, randomized controlled trial. We are going to enroll 780 patients undergoing elective cardiac surgery with planned use of CPB, aortic cross-clamping and two lung ventilation. Patients will be randomized into three treatment groups: 1) no ventilation during CPB; 2) continuous positive airway pressure (CPAP) with positive end-expiratory pressure (PEEP) of 5 cmH2O during CPB; 3) ventilation with 5 acts/minute with tidal volume of 2-3 ml/Kg and a PEEP of 3-5 cmH2O during CPB. The primary end-point will be the incidence of a PaO2/FiO2 ratio \<200 until the time of discharge from the ICU. The secondary end-points will be the incidence of post-operative pulmonary complications and 30-days mortality. Patients will be followed-up to 12 months after the date of randomization. Summary The CPBVENT Trial will determine whether different ventilation strategies during CPB will improve pulmonary outcome in patients undergoing cardiac surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
780

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2014

Typical duration for not_applicable

Geographic Reach
1 country

13 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 8, 2014

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 18, 2014

Completed
8 months until next milestone

Study Start

First participant enrolled

November 1, 2014

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

February 2, 2016

Status Verified

February 1, 2016

Enrollment Period

2.1 years

First QC Date

March 8, 2014

Last Update Submit

February 1, 2016

Conditions

Keywords

cardio-pulmonary bypasscardiac surgerylung injury preventionmechanical ventilationpulmonary insufficiency

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative pulmonary complications

    We aim to assess the number of incidence (defined as percentage of all events) of post-operative pulmonary complications up to 1 year after the surgical intervention. Our goal is to reduce this number with the ventilation during cardio-pulmonary bypass.

    Up to 1 year

Study Arms (3)

Non-ventilation during CPB

PLACEBO COMPARATOR

This group of patients will not be ventilated during the cardio-pulmonary bypass. They will be disconnected from the respirator.

Procedure: Non-ventilation during CPB

Ventilation with CPAP

EXPERIMENTAL

This group will receive a ventilation with CPAP (at least 5 cmH2O) and FiO2 50%-80%

Procedure: Ventilation with CPAPDevice: CPAP

Ventilation with 5 act/minute

EXPERIMENTAL

This group will receive 5 respiratory acts/minute. Tidal volume = 2-3 ml/kg + PEEP = 3-5 cmH2O.

Procedure: Ventilation with 5 act/minuteDevice: Ventilator: 5 act/minute

Interventions

Patients that will not be ventilated during cardio-pulmonary bypass

Non-ventilation during CPB

These patients will receive CPAP (at least 5 cmH2O and FiO2 50%-80%)

Ventilation with CPAP

These patients will receive mechanical ventilation (5 acts/minute) during CPB

Ventilation with 5 act/minute
CPAPDEVICE

Continuous Positive Air Pressure, applicated during cardio-pulmonary bypass

Ventilation with CPAP

Tidal volume = 2-3 ml/kg + PEEP = 3-5 cmH2O.

Ventilation with 5 act/minute

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age \> 18 years old
  • Ability to provide an informed consent
  • Elective surgery
  • Surgical intervention with cardio-pulmonary bypass, aortic clamp and cardioplegia
  • Cardiac valvular surgery, coronary artery surgery, ascending aortic surgery and/or combined
  • Planned cardiac surgery with median sternotomy and bi-pulmonary ventilation

You may not qualify if:

  • Patient refusal to provide informed consent
  • Emergency surgery
  • Patients with previous cardiac surgery
  • Cardiac surgery with planned circulatory arrest or aortic endoprosthesis or TAVI/MitraClip
  • Planned thoracotomy with one lung ventilation
  • Patients with BMI \>30
  • Patients with chronic kidney insufficiency (defined as dialysis)
  • Patients with known respiratory diseases (current respiratory infections, asthma, chronic obstructive pulmonary disease, obstructive apnea syndrome)
  • Patients already intubated in the peri-operative period
  • Patients with pneumonia in the pre-operative period (30 days before surgery)
  • Patients with previous thoracic surgery (pulmonary resection)
  • Patients with: oxygen saturation \< 90% and/or oxygen arterial pressure \< 60 mmHg and/or P/F ratio \<300 and/or carbon dioxide pressure \> 45 mmHg
  • Patients with levels of aspartate aminotransferase (AST) or alanine aminotransferase (ALT) levels increased \>= 2 folds above the upper limit.
  • Patients with ejection fraction \< 40%
  • Patients with pulmonary hypertension (defined as PAPm \> 30mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (13)

Spedali Civili

Brescia, Brescia, 25128, Italy

NOT YET RECRUITING

Azienda Ospedaliera Brotzu

Cagliari, Cagliari, 09134, Italy

NOT YET RECRUITING

P.O. Pineta Grande

Castel Volturno, Caserta, 81030, Italy

RECRUITING

Ospedale San Martino

Genova, Genova, 16132, Italy

NOT YET RECRUITING

IRCCS Monzino

Milan, MI, 20138, Italy

NOT YET RECRUITING

Ospedale San Raffaele

Milan, MI, 20132, Italy

RECRUITING

Azienda Ospedaliero-Universitaria di Parma

Parma, Parma, 43126, Italy

RECRUITING

Azienda Ospedaliera di Perugia

Perugia, Perugia, 06156, Italy

RECRUITING

Azienda Ospedaliera San Carlo

Potenza, Potenza, 85100, Italy

NOT YET RECRUITING

Policlinico universitario Campus biomedico

Roma, Roma, 00128, Italy

RECRUITING

Policlinico Universitario Agostino Gemelli

Roma, Roma, 00168, Italy

NOT YET RECRUITING

Azienda Ospedaliera Universitaria Senese

Siena, Siena, 53100, Italy

RECRUITING

A.O.U. Santa Maria della misericordia

Udine, Udine, 33100, Italy

RECRUITING

Related Publications (1)

  • Bignami E, Guarnieri M, Saglietti F, Maglioni EM, Scolletta S, Romagnoli S, De Paulis S, Paternoster G, Trumello C, Meroni R, Scognamiglio A, Budillon AM, Pota V, Zangrillo A, Alfieri O. Different strategies for mechanical VENTilation during CardioPulmonary Bypass (CPBVENT 2014): study protocol for a randomized controlled trial. Trials. 2017 Jun 7;18(1):264. doi: 10.1186/s13063-017-2008-2.

MeSH Terms

Conditions

Respiratory InsufficiencyPneumothoraxPulmonary AtelectasisPneumonia, AspirationBronchial Spasm

Interventions

Ventilation

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPleural DiseasesLung DiseasesPneumoniaRespiratory Tract InfectionsInfectionsBronchial Diseases

Intervention Hierarchy (Ancestors)

Environment, ControlledEnvironmentEnvironment and Public Health

Study Officials

  • Elena Bignami, MD

    San Raffaele Hospital, Milan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elena Bignami, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

March 8, 2014

First Posted

March 18, 2014

Study Start

November 1, 2014

Primary Completion

December 1, 2016

Study Completion

June 1, 2017

Last Updated

February 2, 2016

Record last verified: 2016-02

Locations